This activity includes an interactive posttest with patient case videos.
Program Description
Pharmacists have frequent encounters and involvement in management of patients with chronic conditions, including persons with diabetes. The use of integrated continuous glucose monitoring (iCGM) devices has continued to increase among persons with diabetes and have been particularly beneficial for persons with type 1 or type 2 diabetes who are taking insulin but not meeting glycemic targets. With multiple iCGM devices available, pharmacists and pharmacy technicians must be familiar with the specific characteristics and nuances in data reporting of each. This article will feature common questions pharmacists and pharmacy technicians may encounter about use of iCGM and draw from evidence-based recommendations and clinical guidelines to establish best practices to address challenges and concerns to improve implementation of iCGM in clinical practice. This activity features interactive patient simulations during which pharmacists can experience making interventions with the use of iCGM for persons with diabetes.
Target audience: Retail pharmacists, health-system pharmacists
Type of activity: Application
Release date: August 12, 2022
Expiration date: August 12, 2023
Time to complete activity: 2.5 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Differentiate among the various integrated continuous glucose monitoring (iCGM) products available
- Determine barriers in the adoption of iCGM in diabetes management
- Explore best practices for the use of iCGM in the management of persons with diabetes
- Investigate common questions about iCGM from persons with diabetes and health care providers
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
